Literature DB >> 17481895

Boswellic acids and glucosamine show synergistic effect in preclinical anti-inflammatory study in rats.

Surjeet Singh1, Anamika Khajuria, Subhash Chandra Taneja, Ravi Kant Khajuria, Jaswant Singh, Ghulam Nabi Qazi.   

Abstract

The present study revealed the synergistic effect of boswellic acid mixture (BA) and glucosamine for anti-inflammatory and anti-arthritic activities in rats. Two studies were conducted, that is, acute anti-inflammatory by carrageenan edema and chronic anti-arthritic by Mycobacterium-induced developing arthritis. Five groups of animals were included in each of the study: the vehicle control, positive control (ibuprofen 100mg/kg), boswellic acids (250 mg/kg), glucosamine (250 mg/kg) and a combination of boswellic acids (125 mg/kg) and glucosamine (125 mg/kg). BA when administered at 250 mg/kg in rats, carrageenan-induced paw edema and Mycobacterium-induced developing arthritis were significantly inhibited. In comparison to boswellic acids, glucosamine when administered at 250 mg/kg showed a mild effect in carrageenan-induced edema and moderate inhibition of paw swelling against developing arthritis. Although the combination of boswellic acids and glucosamine did not affect the acute inflammation to a greater extent yet a significant anti-arthritic activity was observed in rats. In conclusion, a synergistic effect was observed in chronic inflammatory conditions when two chemical entities were administered in combination in preclinical study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17481895     DOI: 10.1016/j.bmcl.2007.04.034

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

1.  Acetyl-11-keto-β-boswellic acid modulates membrane dynamics in benzo(a)pyrene-induced lung carcinogenesis.

Authors:  Priti Bhardwaj; Manoj Kumar; Sunil Kumar Dhatwalia; Mohan Lal Garg; Devinder Kumar Dhawan
Journal:  Mol Cell Biochem       Date:  2019-06-04       Impact factor: 3.396

2.  Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense.

Authors:  U Siemoneit; A Koeberle; A Rossi; F Dehm; M Verhoff; S Reckel; T J Maier; J Jauch; H Northoff; F Bernhard; V Doetsch; L Sautebin; O Werz
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

3.  Boswellic Acids as Effective Antibacterial Antibiofilm Agents.

Authors:  Petr Jaroš; Elizaveta Timkina; Jana Michailidu; Dominik Maršík; Markéta Kulišová; Irena Kolouchová; Kateřina Demnerová
Journal:  Molecules       Date:  2022-06-13       Impact factor: 4.927

Review 4.  Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents.

Authors:  Reen-Yen Kuo; Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2009-08-13       Impact factor: 13.423

Review 5.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

6.  Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata.

Authors:  Alsaba F Raja; Furqan Ali; Inshad A Khan; Abdul S Shawl; Daljit S Arora; Bhahwal A Shah; Subhash C Taneja
Journal:  BMC Microbiol       Date:  2011-03-16       Impact factor: 3.605

7.  Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogens.

Authors:  Alsaba F Raja; Furqan Ali; Inshad A Khan; Abdul S Shawl; Daljit S Arora
Journal:  BMC Res Notes       Date:  2011-10-13

8.  UP446, analgesic and anti-inflammatory botanical composition.

Authors:  Mesfin Yimam; Lidia Brownell; Mandee Pantier; Qi Jia
Journal:  Pharmacognosy Res       Date:  2013-07

9.  Formulation of Nanospanlastics as a Promising Approach for ‎Improving the Topical Delivery of a Natural Leukotriene Inhibitor (3-‎Acetyl-11-Keto-β-Boswellic Acid): Statistical Optimization, in vitro ‎Characterization, and ex vivo Permeation Study.

Authors:  Farid Badria; Eman Mazyed
Journal:  Drug Des Devel Ther       Date:  2020-09-15       Impact factor: 4.162

Review 10.  Porphyromonas gingivalis: where do we stand in our battle against this oral pathogen?

Authors:  Kaitlind C Howard; Octavio A Gonzalez; Sylvie Garneau-Tsodikova
Journal:  RSC Med Chem       Date:  2021-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.